We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
70 hedge funds and large institutions have $896M invested in ESSA Pharma in 2021 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
500% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 6
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
227% more capital invested
Capital invested by funds: $274M → $896M (+$621M)
122% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 9
75% more funds holding
Funds holding: 40 → 70 (+30)
22.48% more ownership
Funds ownership: 68.8% → 91.28% (+22%)
Holders
70
Holders Change
+30
Holders Change %
+75%
% of All Funds
1.23%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.07%
New
36
Increased
20
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$42.4M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$31.4M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$23.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.5M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$16M |
